Cargando…
Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
Immune checkpoint inhibitors (ICIs) have become a new hope for many patients with advanced cancer by blocking tumour immune evasion. However, with the widespread use of ICIs, immune‐related adverse events (irAEs) have also been discovered and reported increasingly. Immune‐related myocarditis, the mo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065848/ https://www.ncbi.nlm.nih.gov/pubmed/35322589 http://dx.doi.org/10.1002/ehf2.13912 |